OraSure Technologies, Inc.
OraSure is certain it can deliver results. The oral specimen kits and other diagnostic tests developed by OraSure Technologies are designed to detect drug use and certain infectious diseases, such as HIV. The company's OraSure products use oral specimens rather than traditional blood- or urine-based methods to test for HIV. Its Intercept line uses oral samples to test for marijuana, cocaine, opiates, PCP, and amphetamines. OraSure has also developed a rapid HIV blood diagnostic testing method. The company sells its products in the US and internationally through direct agents and independent distributors, primarily to public health clinics, hospitals, and doctors' offices.
Contact Details
Executives
Chairman
Douglas G. Watson
President, CEO, and Director
Douglas A. Michels